Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Multiple studies had already shown that their benefits might go beyond weight loss and diabetes. Those studies showed that patients taking GLP-1 medication fared better against a wide range of ...

“Diabetes, high blood pressure, sleep apnea, all of those things — they can get better, but that's because of the weight loss ... best of what PEOPLE has to offer, from celebrity news to compelling ...

St. Louis Health Care System have systematically evaluated health outcomes among more than 2 million people with diabetes taking the popular weight-loss drugs. The findings are published Jan. 20 ...

The newest weight-loss drugs ... on the health outcomes associated with the drugs known as GLP-1 receptor agonists. These medications began as diabetes treatments to lower blood glucose levels ...

Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight loss and ...